As per Future Market Insights’ latest industry analysis, the valuation for the global clinical next-generation sequencing (NGS) data analysis market was around US$ 2.3 Billion in 2022, and the market is projected to exhibit growth at a CAGR of 17.4% over the forecast period, with an estimated valuation of around US$ 13.1 Billion in 2033.
Increasing prevalence of cancer, rise in geriatric population and lifestyle diseases globally, technological advancements in the field of genomic-based bioinformatics tools, and increasing government funding for life science projects, are some of the significant factors accelerating the market growth.
The demand for precise and quick sequencing interpretation tools and algorithms that may accelerate data processing is growing as clinical next-generation sequencing (NGS) technology progresses and their usage in clinical diagnosis, genomic research, and personalized treatments for a variety of disorders increases.
It is anticipated that sequencing programs would expand in scope because of rising genetic data production and declining sequencing costs. As a result, there is a higher need for complex bioinformatics pipelines that include state-of-the-art, efficient solutions.
Market Competition
Agilent Technologies, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., Eurofins Scientific, BGI Group, Qiagen, Roche Diagnostics, DNA Star, Inc., Bio-Rad Laboratories, Inc., Congenica Ltd., Theragen Etex Inc., PerkinElmer, Inc., Partek Inc., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Golden Helix, Inc., and BioDatomics.
Browse More@ https://www.futuremarketinsights.com/reports/clinical-ngs-data-analysis-market
Key Market Segments Covered in the Clinical Next-Generation Sequencing (NGS) Data Analysis Industry Research
Solution and Services:
- NGS Data Analysis Tools
- Sequence Alignment Tools
- Alignment Visualization Tools
- Gene Prediction Tools
- Variant Analysis Tools
- Others
- Platforms
- Next-Generation Sequencing (NGS) Platforms
- Clinical Informatics Platforms
- Others
- NGS Data Analysis & Sequencing Services
- Whole-Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Comprehensive genomic profiling (CGP)
- Custom Panels
- RNA Sequencing
- Other Sequencing Services
- NGS Storage, Management & Cloud Computing Platform
Technology:
- Sequencing by Synthesis (SBS)
- Nanopore Sequencing
- Single-Molecule Real-Time (SMRT) Sequencing
- Others
Application:
- Diagnostics
- Drug Discovery & Designing
- Medical Research
- Others
End User:
- Hospitals & Clinics
- Academic Institutes & Research Centers
- Biotechnology Companies
- Life Science Technology Vendors
- Others
